Fibrosing Cholestatic Hepatitis C Post-Liver Transplantation: A Case Study

Authors

Layla Hatem, Thomas Jefferson UniversityFollow
Wei Jiang, MD, PhD, Thomas Jefferson UniversityFollow

Document Type

Poster

Publication Date

6-2014

Abstract

Introduction:

Liver Transplantation:

• Hepatitis C infection is the most common indication for liver transplantation in the US
• HCV infection of the liver allograft occurs within hours from circulating virions.

-Serum RNA levels are observed in the first several weeks.

-Acute hepatitis occurs in 2-6 months

-Chronic hepatitis occurs in 3-9 months

***Persistence of HCV infection is the rule after transplantation due to immune suppression

Chronic recurrent HCV infection post transplantation

• There are four distinct patterns of recurrent chronic HCV in the liver allograft.

-Usual chronic HCV (>70%)

-Fibrosing Cholestatic Hepatitis C (5-10%)

-Plasma cell-rich HCV

-HCV overlapping with rejection or autoimmune hepatitis

Recommended Citation